Abstract
Review the epidemiology, diagnosis and management of ADHD Comorbidities with Depression, Anxiety, and Suicide
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Arias AJ et al (2008) Correlates of co-occurring ADHD in drugdependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 33(9):1199–1207
Balazs J, Miklosi M, Kereszteny A, Dallos G, Gadoros J (2014) Attention-deficit hyperactivity disorder and suicidality in a treatment naïve sample of children and adolescents. J Affect Disord 152–154:282–287
Bangs ME, Emslie GJ, Spencer TJ et al; Atomoxetine ADHD and Comorbid MDD Study Group (2007) Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol 17(4):407–20
Bangs ME et al (2008) Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry 47(2):209–218
Biederman J et al (2008) New insights into the comorbidity between ADHD and major depression in adolescent and young adult females. J Am Acad Child Adolesc Psychiatry 47(4):426–434
Bond DJ, Hadjipavlou G, Lam RW et al; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry 24(1):23–37
Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW (1997) Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 769(1):135–140
Bushe CJ, Savill NC (2013) Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials. Child Adolesc Psychiatr Ment Health 7:19
Carlat DA (2012) Evidence bsed somatic treatment of depression in adults. Psych Clin N Am 35:131–142
Cottencin O, Nandrino JL, Karila L, Mezerette C, Danel T (2009) A case-comparison study of executive functions in alcohol-dependent adults with maternal history of alcoholism. Eur Psychiatry 24(3):195–200
Evans C, Blackburn D, Butt P, Dattani D (2004) Use and abuse of methylphenidate in attention-deficit/hyperactivity disorder beware of legitimate prescriptions being diverted. Can Pharmacists J/Revue des Pharmaciens du Can 137(6):30–35
Findling RL (1996) Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol 6(3):165–175
Fishman PA, Stang PE, Hogue SL (2007) Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care. J Clin Psychiatry 68(2):248–253
Furczyk K, Thome J (2014) Adult ADHD and suicide. Atten Defic Hyperact Disord 6(3):153–158
Goodman D, Happell B (2006) The efficacy of family intervention in adolescent mental health. Int J Psychiatr Nurs Res 12(1):1364–1377
Goodman DW, Thase ME (2009) Recognizing ADHD in adults with comorbid mood disorders: implications for identification and management. Postgrad Med 121(5):20–30
Graham J et al (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20(1):17–37
Greenhill LL, Pliszka S, Dulcan MK et al; American Academy of Child and Adolescent Psychiatry (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41(2 Suppl):26S–49S
Health Canada warning on ADHD medications: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52759a-eng.php
Huntley Z et al (2012) Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatry 6(12):223
Hyperlink: http://www.caddra.ca
Impey M, Heun R (2012) Completed suicide, ideation and attempt in attention deficit hyperactivity disorder. Acta Psychiatr Scand 125(2):93–102
Jollant F, Guillaume S, Jaussent I, Bellivier F, Leboyer M, Castelnau D, Malafosse A, Courtet P (2007) Psychiatric diagnoses and personality traits associated with disadvantageous decision-making. Eur Psychiatry 22(7):455–461, Epub 2007 Aug 30
Keresztėny A, Dallos G, Miklósi M, Róka A, Gadoros J, Balazs J (2012) Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence. Psychiatr Hung 27(3):165–173
Kessler RC, Adler L, Barkley R et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723
Ljung T, Chen Q, Lichtenstein P, Larsson H (2014) Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden. JAMA Psychiatry 71(8):958–964
Masunami T, Okazaki S, Maekawa H (2009) Decision-making patterns and sensitivity to reward and punishment in children with attention-deficit hyperactivity disorder. Int J Psychophysiol 72(3):283–288
McIntyre RS, Kennedy SH, Soczynska JK et al (2010) Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry 12(3)
Miller M, Sheridan M, Cardoos SL, Hinshaw SP (2013) Impaired decision-making as a young adult outcome of girls diagnosed with attention-deficit/hyperactivity disorder in childhood. J Int Neuropsychol Soc 19(1):110–114
Murphy KR, Barkley RA, Bush T (2002) Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history. J Nerv Ment Dis 190(3):147–157
Nasser EH, Overholser JC (1999) Assessing varying degrees of lethality in depressed adolescent suicide attempters. Acta Psychiatr Scand 99(6):423–431
Park S et al (2011) Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study. Psychiatry Res 186(2–3):378–383
Paternite CE, Loney J, Salisbury H, Whaley MA (1999) Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol 9(3):169–184
Patros CH, Hudec KL, Alderson RM, Kasper LJ, Davidson C, Wingate LR (2013) Symptoms of attention-deficit/hyperactivity disorder (ADHD) moderate suicidal behaviors in college students with depressed mood. J Clin Psychol 69(9):980–993
Paxton GA, Cranswick NE (2008) Acute suicidality after commencing atomoxetine. J Paediatr Child Health 44(10):596–598
Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M, Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder (2006) The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45(6):642–657
Posner MI, Rothbart MK (2007) Research on attention networks as a model for the integration of psychological science. Annu Rev Psychol 58:1–23
Rydén E, Thase ME, Stråht D, Aberg-Wistedt A, Bejerot S, Landén M (2009) A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 120(3):239–246
Semiz UB et al (2008) Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry 42(5):405–413
Stickley A, Koyanagi A, Ruchkin V, Kamio Y (2016) Attention-deficit/hyperactivity disorder symptoms and suicide ideation and attempts: findings from the adult psychiatric morbidity survey 2007. J Affect Disord 189:321–328
Weiss M, Hechtman L, Adult ADHD Research Group (2006) A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 67(4):611–619
Young J (2008) Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 19(2):216–228, vii, Review. PubMed PMID: 18822828
Bibliography
Asberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33(10):1193–1197
Barbaresi WJ et al (2013) Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics 131(4):637–644
Blum K et al (2008) Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat 4(5):893–918
Chen Q, Sjölander A, Runeson B, D’Onofrio BM, Lichtenstein P, Larsson H (2014) Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study. BMJ 348:g3769
Chronis-Tuscano A et al (2010) Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 67(10):1044–1051
Corruble E et al (2003) Defense styles, impulsivity and suicide attempts in major depression. Psychopathology 36(6):279–284
Do Mantyla T, Still J, Gullberg S, Del Missier F (2012) Decision making in adults with ADHD. J Atten Disord 16(2):164–173
Fayyad J et al (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409
Goldston DB et al (2009) Psychiatric diagnoses as contemporaneous risk factors for suicide attempts among adolescents and young adults: developmental changes. J Consult Clin Psychol 77(2):281–290
Goodman G, Gerstadt C, Pfeffer CR, Stroh M, Valdez A (2008) ADHD and aggression as correlates of suicidal behavior in assaultive prepubertal psychiatric inpatients. Suicide Life Threat Behav 38(1):46–59
Greening L et al (2008) Pathways to suicidal behaviors in childhood. Suicide Life Threat Behav 38(1):35–45
Gunter TD, Chibnall JT, Antoniak SK, McCormick B, Black DW (2012) Relative contributions of gender and traumatic life experience to the prediction of mental disorders in a sample of incarcerated offenders. Behav Sci Law 30(5):615–630
Hardy SE (2009) Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother 7(1):34–59
Hinshaw SP (2012) Prospective follow-up of girls with attention-deficit/hyperactivity disorder into early adulthood: continuing impairment includes elevated risk for suicide attempts and selfinjury. J Consult Clin Psychol 80(6):1041–1051
Hurtig T, Taanila A, Moilanen I, Nordstrom T, Ebeling H (2012) Suicidal and self-harm behaviour associated with adolescent attention deficit hyperactivity disorder-a study in the Northern Finland Birth Cohort 1986. Nord J Psychiatry 66:320–328
Klein-Schwartz W (2002) Abuse and toxicity of methylphenidate. Curr Opin Pediatr 14(2):219–223. Review
Kollins SH (2008) A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders. Curr Med Res Opin 24(5):1345–1357. doi:10.1185/030079908X280707, Epub 2008 Apr 1. Review. PubMed PMID: 18384709
Kollins SH (2008) ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 12(2):115–125. doi:10.1177/1087054707311654, Epub 2008 Jan 11. Review. PubMed PMID: 18192623
Manor I et al (2010) Possible association between attention deficit hyperactivity disorder and attempted suicide in adolescents – a pilot study. Eur Psychiatry 25(3):146–150
McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC (2009) Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database. Drug Saf 32(11):1089–1096
Nicoli M, Bouchez S, Nieto I, Gasquet I, Kovess V, Lepine JP (2012) Prevalence and risk factors for suicide ideation, plans and attempts in the French general population: results from the ESEMeD study. Encéphale 38(4):296–303
Nordstrom P et al (1994) CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24(1):1–9
Ozdemir E, Karaman MG, Yurteri N, Erdogan A (2010) A case of suicide attempt with long-acting methylphenidate (Concerta). Atten Defic Hyperact Disord 2(3):103–105
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6):942–948
Putnins AL (2005) Correlates and predictors of self-reported suicide attempts among incarcerated youths. Int J Offender Ther Comp Criminol 49(2):143–157
Santosh PJ, Sattar S, Canagaratnam M (2011) Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults. CNS Drugs 25(9):737–763
Sharav VH (2003) The impact of the food and drug administration modernization act on the recruitment of children for research. Ethical Hum Sci Serv 5(2):83–108
Swann AC, Steinberg JL, Lijffijt M, Moeller FG (2008) Impulsivity: differential relationship to depression and mania in bipolar disorder. J Affect Disord 106(3):241–248. Epub
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21–31. doi:10.1097/chi.0b013e31815a56f1, Review. PubMed PMID: 18174822
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sadek, J. (2017). ADHD Comorbidities with Depression, Anxiety, and Suicide. In: Clinician’s Guide to Adult ADHD Comorbidities. Springer, Cham. https://doi.org/10.1007/978-3-319-39794-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-39794-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39792-4
Online ISBN: 978-3-319-39794-8
eBook Packages: MedicineMedicine (R0)